
### [MONDO:0005554](http://purl.obolibrary.org/obo/MONDO_0005554)
**Label:** rheumatic disease

**Subclasses:** [MONDO:0008418](http://purl.obolibrary.org/obo/MONDO_0008418) (scleroderma, familial progressive), [MONDO:0011429](http://purl.obolibrary.org/obo/MONDO_0011429) (juvenile rheumatoid arthritis), [MONDO:0008383](http://purl.obolibrary.org/obo/MONDO_0008383) (rheumatoid arthritis), [MONDO:0018456](http://purl.obolibrary.org/obo/MONDO_0018456) (polyarticular juvenile idiopathic arthritis), [MONDO:0019432](http://purl.obolibrary.org/obo/MONDO_0019432) (rheumatoid factor-negative juvenile idiopathic arthritis), [MONDO:0019433](http://purl.obolibrary.org/obo/MONDO_0019433) (Oligoarticular juvenile idiopathic arthritis), [MONDO:0007915](http://purl.obolibrary.org/obo/MONDO_0007915) (systemic lupus erythematosus (disease)), [MONDO:0007319](http://purl.obolibrary.org/obo/MONDO_0007319) (familial calcium pyrophosphate deposition), 

**Corr. equiv. classes:** [OMIM:152700](http://purl.obolibrary.org/obo/OMIM_152700), [OMIM:604302](http://purl.obolibrary.org/obo/OMIM_604302), [Orphanet:85408](http://www.orpha.net/ORDO/Orphanet_85408), [OMIM:180300](http://purl.obolibrary.org/obo/OMIM_180300), [Orphanet:92](http://www.orpha.net/ORDO/Orphanet_92), [Orphanet:1416](http://www.orpha.net/ORDO/Orphanet_1416), [OMIM:181750](http://purl.obolibrary.org/obo/OMIM_181750), [OMIM:118600](http://purl.obolibrary.org/obo/OMIM_118600), [Orphanet:404580](http://www.orpha.net/ORDO/Orphanet_404580), [Orphanet:85410](http://www.orpha.net/ORDO/Orphanet_85410), 

**Class expressions from DL-Learner:**

- [HP:0001369](http://purl.obolibrary.org/obo/HP_0001369) (Arthritis) and [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) 65.00%
- [HP:0001367](http://purl.obolibrary.org/obo/HP_0001367) (Abnormal joint morphology) and [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) 65.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and (not ([HP:0410008](http://purl.obolibrary.org/obo/HP_0410008) (Abnormality of the peripheral nervous system))) 65.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and (not ([HP:0100326](http://purl.obolibrary.org/obo/HP_0100326) (Immunologic hypersensitivity))) 65.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and (not ([HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology))) 65.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and (not ([HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system))) 65.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and (not ([HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract))) 65.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and (not ([HP:0012440](http://purl.obolibrary.org/obo/HP_0012440) (Abnormal biliary tract morphology))) 65.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and (not ([HP:0012203](http://purl.obolibrary.org/obo/HP_0012203) (Onychomycosis))) 65.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and (not ([HP:0012116](http://purl.obolibrary.org/obo/HP_0012116) (Abnormal albumin level))) 65.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and (not ([HP:0011971](http://purl.obolibrary.org/obo/HP_0011971) (Dermatographic urticaria))) 65.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and (not ([HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site))) 65.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and (not ([HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality))) 65.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and (not ([HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract))) 65.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and (not ([HP:0011017](http://purl.obolibrary.org/obo/HP_0011017) (Abnormality of cell physiology))) 65.00%


